Abstract #2808

Prediction of multiple sclerosis clinical progression using whole brain adiabatic T1rho and Relaxation Along a Fictitious Field imaging

Ivan Jambor¹, Aida Steiner², Marko Pesola³, Timo Liimatainen⁴, Marcus Sucksdorff³, Eero Rissanen ², Laura Airas², Hannu Aronen³, and Harri Merisaari³

¹Icahn School of Medicine at Mount Sinai, New York, NY, United States, ²Turku University Hospital, Turku, Finland, ³University of Turku, Turku, Finland, ⁴University of Oulu, Oulu, Finland

In this single center prospective clinical trial, we have shown feasibility of whole brain of T1ρadiab and TRAFF2 at 3T. Both of these methods provided higher lesion-to-normal appearing white matter contrast compared with conventional used T1-weighted imaging, and demonstrated potential to predict multiple sclerosis disease severity scores (EDSS, MSSS) at the time of imaging and 1-year follow-up. These encouraging findings stimulate further application of T1ρadiab and TRAFF2 at 3T in patients with multiple sclerosis.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.